Market Place
Sourcing Support
Novo Nordisk Agrees With U.S. Administration To Expand Access
07 Nov 2025 //
GLOBENEWSWIRE
FDA Grants Priority Review Vouchers To Wegovy & Casgevy
07 Nov 2025 //
BIOSPACE
Needles, Pens & Pressure: The GLP-1 Challenge
05 Nov 2025 //
EXPRESSPHARMA
India Strategic Launchpad For Next Wave Of Obesity Care
05 Nov 2025 //
ECONOMICTIMES
Veru to Present Two Abstracts at Obesityweek 2025
31 Oct 2025 //
GLOBENEWSWIRE
Rani to Present Oral Semaglutide Data via RaniPill at ObesityWeek
30 Oct 2025 //
GLOBENEWSWIRE
Biomea Fusion To Present Poster Presentations At Obesityweek 2025
30 Oct 2025 //
GLOBENEWSWIRE
Novo Nordisk to Unveil Wegovy 2.4mg Data at AASLD Meeting
28 Oct 2025 //
PR NEWSWIRE
Neumora Therapeutics Shows Superior Weight Loss With NMRA-215
27 Oct 2025 //
GLOBENEWSWIRE
Innovent`s Mazdutide Outperforms Semaglutide In Glycemic Control
27 Oct 2025 //
PR NEWSWIRE
Dr Reddy`s Gets Nod To Make Generic Semaglutide For Weight Loss
24 Oct 2025 //
ECONOMICTIMES
Ventyx`s CV Drug Rapidly Reduces Cardio Risk Biomarker
23 Oct 2025 //
FIERCE BIOTECH
Ventyx Biosciences Reports Positive Phase 2 Results For VTX3232
22 Oct 2025 //
GLOBENEWSWIRE
Novo`s Rybelsus Gains FDA Expansion To Reduce Risk Of MACE
21 Oct 2025 //
FIERCE PHARMA
Novo Nordisk To Unveil Oral Semaglutide 25mg Data at ObesityWeek
20 Oct 2025 //
PR NEWSWIRE
FDA Approves Novo`s oral semaglutide For Cardiovascular Risk
17 Oct 2025 //
PR NEWSWIRE
Novo, Lilly Shares Drop As Trump Promises $150 Ozempic
17 Oct 2025 //
BIOSPACE
Trump Says Price Of Ozempic Will Be Lowered
16 Oct 2025 //
REUTERS
Medvi Expands Telehealth Access To Oral GLP-1 Tablets
14 Oct 2025 //
GLOBENEWSWIRE
Resalis Report Fat-Selective Weight Loss With RES-010 In Primates
07 Oct 2025 //
GLOBENEWSWIRE
Skye Bioscience Reports Ph2a CBeyond Data For Nimacimab Therapy
06 Oct 2025 //
GLOBENEWSWIRE
Skye`s CB1 Blocker Fails To Reduce Weight In Obesity Study
06 Oct 2025 //
FIERCE BIOTECH
Aspire Bio To Present At Noble Capital Markets 2025 Growth Conf
03 Oct 2025 //
PHARMAWEB
European Doctors Recommend Novo And Lilly Weight-Loss Drugs
02 Oct 2025 //
ECONOMICTIMES
Forepass® Surpasses Semaglutide, Achieving 8X Weight Loss
01 Oct 2025 //
BUSINESSWIRE
Novo Nordisk Launches Ozempic In India, Boosting GLP-1 Market
01 Oct 2025 //
EXPRESSPHARMA
LIFMD Collaborates With Novo Nordisk, Offering Ozempic
30 Sep 2025 //
GLOBENEWSWIRE
Weight-Loss Drug Ozempic To Debut In India Soon
26 Sep 2025 //
ECONOMICTIMES
Innovent`s Weight-Loss Drug Highlights China Challenge for Novo
22 Sep 2025 //
REUTERS
Ascletis Reveal ASC47 with Semaglutide, 56.2% More Weight Loss
21 Sep 2025 //
PR NEWSWIRE
Indian API Makers Gear Up for Semaglutide Demand
20 Sep 2025 //
PRESS RELEASE
Europe`s CHMP Approves Novo`s Kyinsu, Bayer`s Lynkuet
19 Sep 2025 //
FIERCE PHARMA
Novo Boosts Wegovy Pill Case Before FDA Decision
18 Sep 2025 //
FIERCE PHARMA
Lilly`s Oral GLP-1 Orforglipron Superior to Semaglutide in Trial
17 Sep 2025 //
PR NEWSWIRE
Serena Williams Promotes GLP-1s for Ro Amid Pharma Oversight
17 Sep 2025 //
BIOSPACE
Indian Pharma Giants Dr Reddy`s and Macleods Gear Up for Ozempic
17 Sep 2025 //
ECONOMICTIMES
Novo Says Wegovy Pill Shows Comparable Weight-Loss to Injectable
17 Sep 2025 //
REUTERS
Biomea Fusion Shows Icovamenib`s Synergy with Semaglutide in T2D
16 Sep 2025 //
GLOBENEWSWIRE
EU Approves Novo`s Oral Semaglutide, Reduce Cardiovascular Death
15 Sep 2025 //
GLOBENEWSWIRE
Novo’s Wegovy Cuts Food Noise, Lifts Mental Well-Being
15 Sep 2025 //
GLOBENEWSWIRE
BioNxt Advances Semaglutide ODF Program with Prototype
15 Sep 2025 //
ACCESSWIRE
WHO Adds Popular Weight-Loss Drugs to Essential Medicines List
11 Sep 2025 //
ECONOMICTIMES
Wegovy-Maker Novo to Slash 9,000 Jobs as Competition Heats Up
10 Sep 2025 //
REUTERS
Enforcement Report - Week of September 10, 2025
10 Sep 2025 //
FDA
Novo, Lilly Obesity Drugs Deemed `Highly Cost-Effective` by ICER
09 Sep 2025 //
FIERCE PHARMA
WHO Includes GLP-1s in Essential Medicines List
08 Sep 2025 //
BIOSPACE
Europe Warns of Surge in Illegal Obesity Drugs
05 Sep 2025 //
FIERCE PHARMA
Novo Nordisk to Unveil Semaglutide Data on `Food Noise`
05 Sep 2025 //
GLOBENEWSWIRE
Vivani Update on NPM-139 Semaglutide Implant in weight Management
04 Sep 2025 //
GLOBENEWSWIRE
Skye Completes 26-week Treatment Phase in Phase 2a CBeyond™ Study
02 Sep 2025 //
GLOBENEWSWIRE
BioNxt Begins Lab-Scale ODF Development with Semaglutide API
02 Sep 2025 //
ACCESSWIRE
Novo’s Wegovy Cuts Risk of Heart Attack or Death by 57%
31 Aug 2025 //
GLOBENEWSWIRE
Novo`s Wegovy Cuts Heart Risk by 57% versus Rival Lilly Drug
30 Aug 2025 //
REUTERS
Cheaper Obesity Drugs: Cure or Crisis for India?
25 Aug 2025 //
PRESS RELEASE
IMA Cautions Against Misuse of Weight-Loss Drugs Wegovy, Mounjaro
23 Aug 2025 //
ECONOMICTIMES
CDSCO issues Alert on Novo Drugs After Reported Theft
22 Aug 2025 //
ECONOMICTIMES
Parker Waichman Files Suit for Ozempic-Linked NAION Vision Loss
20 Aug 2025 //
PR NEWSWIRE
Novo to Showcase Wegovy & Ozempic Benefits at ESC Congress 2025
20 Aug 2025 //
GLOBENEWSWIRE
Canada Approves Ozempic to Cut Risk of Kidney Failure
20 Aug 2025 //
REUTERS
Novo Nordisk Unveils $499 Cash-Pay Ozempic Offering
19 Aug 2025 //
FIERCE PHARMA
